Skip to content
value.today

PepGen Inc.: insider trading

88 trades by 15 directors, officers and 10% owners since 2022, from their SEC Form 4 and 5 filings.

Bought, 12 months
$43.1 M
1 purchase by 1 insider
Sold, 12 months
$59 K
7 sales by 4 insiders
Bought, 3 months
$43.1 M
1 purchase
Sold, 3 months
$0
0 sales

Insider buying and selling by month

Open-market purchases and sales by value, last three years.

$43.1 M-$552 K$0Nov 2023: bought $7 K (1 trades), sold $0 (0 trades)Nov 23Feb 2024: bought $27.2 M (1 trades), sold $0 (0 trades)May 2024: bought $0 (0 trades), sold $134 K (1 trades)MayJun 2024: bought $0 (0 trades), sold $354 K (5 trades)Jul 2024: bought $0 (0 trades), sold $552 K (7 trades)JulFeb 2025: bought $0 (0 trades), sold $5 K (2 trades)Apr 2025: bought $61 K (2 trades), sold $0 (0 trades)AprMay 2025: bought $10 K (1 trades), sold $0 (0 trades)Sep 2025: bought $30.6 M (2 trades), sold $0 (0 trades)SepMar 2026: bought $0 (0 trades), sold $58 K (6 trades)May 2026: bought $0 (0 trades), sold $2 K (1 trades)MayNov 2026: bought $43.1 M (1 trades), sold $0 (0 trades)
Bought (open market)Sold (open market)Hover a month for the totals

Insiders (15)

Each insider's latest direct holding and their open-market trades of the last 12 months, most recent first.

PepGen Inc. insiders
InsiderShares owned directlyBought, 12 mSold, 12 mLatest trade
Ra Capital Management, L.P.Director, 10% owner—$43.1 M—
Kasra KasraianChief Technical Officer50,074—$2 K
James G. McArthurPresident and CEO, Director296,326—$33 K
Noel DonnellyChief Financial Officer111,603—$13 K
Paul StreckEVP, Head of R&D76,226—$12 K
Joseph VittiglioChief Business & Legal Officer65,717——
Oxford Science Enterprises plcFormer 10% Owner4.96 M——
RA Capital Healthcare Fund LPDirector, 10% owner———
Mary Beth DeLenaGeneral Counsel14,968——
Michelle L. MellionChief Medical Officer0——
Niels SvenstrupSVP, Chem. Mfg & Controls0——
Peter KolchinskyDirector, 10% owner———
Jaya GoyalEVP, Res. & Preclin. Dev.0——
Deerfield Private Design Fund V, L.P.10% owner———
Laurie KeatingDirector4,166——

Trades#

PepGen Inc.: insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Ra Capital Management, L.P.Director, 10% ownerBuyindirect+8.63 M$5.000$43.1 M27.18 MForm 4
filed Kasra KasraianChief Technical OfficerSell10b5-1 plan-1,233$1.410$2 K50,074Form 4
filed James G. McArthurPresident and CEO, DirectorSell10b5-1 plan-5,144$6.230$32 K296,457Form 4
filed Paul StreckEVP, Head of R&DSell10b5-1 plan-1,832$6.230$11 K76,273Form 4
filed Noel DonnellyChief Financial OfficerSell10b5-1 plan-2,032$6.230$13 K111,655Form 4
filed James G. McArthurPresident and CEO, DirectorSell10b5-1 plan-131$6.330$829296,326Form 4
filed Noel DonnellyChief Financial OfficerSell10b5-1 plan-52$6.330$329111,603Form 4
filed Paul StreckEVP, Head of R&DSell10b5-1 plan-47$6.290$29676,226Form 4
filed Kasra KasraianChief Technical OfficerGrant or award+34,557——51,307Form 4
filed Joseph VittiglioChief Business & Legal OfficerGrant or award+30,717——65,717Form 4
filed Paul StreckEVP, Head of R&DGrant or award+50,300——78,105Form 4
filed James G. McArthurPresident and CEO, DirectorGrant or award+187,688——301,601Form 4
filed Noel DonnellyChief Financial OfficerGrant or award+76,793——113,687Form 4
filed Joseph VittiglioChief Business & Legal OfficerGrant or award+35,000——35,000Form 4
filed Oxford Science Enterprises plcFormer 10% OwnerBuy+200,000$3.200$640 K4.96 MForm 4
filed RA Capital Healthcare Fund LPDirector, 10% ownerBuyindirect+9.38 M$3.200$30.0 M18.55 MForm 4
filed Paul StreckEVP, Head of R&DBuy+8,375$1.240$10 K27,805Form 4
filed Kasra KasraianChief Technical OfficerGrant or award+16,750——16,750Form 4
filed James G. McArthurPresident and CEO, DirectorBuy+10,000$1.360$14 K113,913Form 4
filed James G. McArthurPresident and CEO, DirectorBuy+41,500$1.150$48 K103,913Form 4
filed James G. McArthurPresident and CEO, DirectorGrant or award+60,719——62,413Form 4
filed Paul StreckEVP, Head of R&DGrant or award+19,430——19,430Form 4
filed Mary Beth DeLenaGeneral CounselGrant or award+13,400——14,968Form 4
filed Noel DonnellyChief Financial OfficerGrant or award+23,283——24,956Form 4
filed Mary Beth DeLenaGeneral CounselSell10b5-1 plan-1,432$1.680$2 K1,568Form 4
filed Noel DonnellyChief Financial OfficerSell10b5-1 plan-1,527$1.680$3 K1,673Form 4
filed Mary Beth DeLenaGeneral CounselGrant or award+3,000——3,000Form 4
filed Noel DonnellyChief Financial OfficerGrant or award+3,200——3,200Form 4
filed Michelle L. MellionChief Medical OfficerOption exercise10b5-1 plan+7,571$10.21$77 K7,571Form 4
filed Michelle L. MellionChief Medical OfficerSell10b5-1 plan-7,571$18.06$137 K0Form 4
filed Michelle L. MellionChief Medical OfficerOption exercise10b5-1 plan+201$10.21$2 K201Form 4
filed Michelle L. MellionChief Medical OfficerSell10b5-1 plan-201$18.01$4 K0Form 4
filed Michelle L. MellionChief Medical OfficerOption exercise10b5-1 plan+12,625$10.21$129 K12,625Form 4
filed Michelle L. MellionChief Medical OfficerSell10b5-1 plan-12,625$18.20$230 K0Form 4
filed Michelle L. MellionChief Medical OfficerOption exercise10b5-1 plan+5,901$10.21$60 K5,901Form 4
filed Michelle L. MellionChief Medical OfficerSell10b5-1 plan-5,901$18.00$106 K0Form 4
filed Michelle L. MellionChief Medical OfficerOption exercise10b5-1 plan+3,288$10.21$34 K3,288Form 4
filed Michelle L. MellionChief Medical OfficerSell10b5-1 plan-3,288$18.04$59 K0Form 4
filed Michelle L. MellionChief Medical OfficerOption exercise10b5-1 plan+37$10.21$37837Form 4
filed Michelle L. MellionChief Medical OfficerSell10b5-1 plan-37$18.07$6690Form 4
filed Michelle L. MellionChief Medical OfficerOption exercise10b5-1 plan+875$10.21$9 K875Form 4
filed Michelle L. MellionChief Medical OfficerSell10b5-1 plan-875$18.01$16 K0Form 4
filed Michelle L. MellionChief Medical OfficerOption exercise10b5-1 plan+9,260$10.21$95 K9,260Form 4
filed Michelle L. MellionChief Medical OfficerSell10b5-1 plan-9,260$18.19$168 K0Form 4
filed Michelle L. MellionChief Medical OfficerOption exercise10b5-1 plan+1,086$10.21$11 K1,086Form 4
filed Michelle L. MellionChief Medical OfficerSell10b5-1 plan-1,086$18.06$20 K0Form 4
filed Michelle L. MellionChief Medical OfficerOption exercise10b5-1 plan+500$10.21$5 K500Form 4
filed Michelle L. MellionChief Medical OfficerSell10b5-1 plan-500$18.04$9 K0Form 4
filed Michelle L. MellionSVP, Clinical DevelopmentOption exercise10b5-1 plan+1,411$10.21$14 K1,411Form 4
filed Michelle L. MellionSVP, Clinical DevelopmentSell10b5-1 plan-1,411$18.00$25 K0Form 4
filed Michelle L. MellionSVP, Clinical DevelopmentOption exercise10b5-1 plan+7,245$10.21$74 K7,245Form 4
filed Michelle L. MellionSVP, Clinical DevelopmentSell10b5-1 plan-7,245$18.09$131 K0Form 4
filed Niels SvenstrupSVP, Chem. Mfg & ControlsSell10b5-1 plan-10,000$13.41$134 K0Form 4
filed Peter KolchinskyDirector, 10% ownerBuyindirect+2.56 M$10.64$27.2 M9.18 MForm 4
filed James G. McArthurPresident and CEO, DirectorBuy+1,694$4.170$7 K1,694Form 4
filed James G. McArthurPresident and CEO, DirectorOption exercise10b5-1 plan+2,381$2.710$6 K2,381Form 4
filed James G. McArthurPresident and CEO, DirectorSell10b5-1 plan-2,381$16.04$38 K0Form 4
filed James G. McArthurPresident and CEO, DirectorOption exercise10b5-1 plan+8,419$2.710$23 K8,419Form 4
filed James G. McArthurPresident and CEO, DirectorSell10b5-1 plan-8,419$16.23$137 K0Form 4
filed James G. McArthurPresident and CEO, DirectorOption exercise10b5-1 plan+18,150$2.710$49 K18,150Form 4
filed James G. McArthurPresident and CEO, DirectorSell10b5-1 plan-18,150$16.18$294 K0Form 4
filed James G. McArthurPresident and CEO, DirectorOption exercise10b5-1 plan+500$2.710$1 K500Form 4
filed James G. McArthurPresident and CEO, DirectorSell10b5-1 plan-500$16.06$8 K0Form 4
filed James G. McArthurPresident and CEO, DirectorOption exercise10b5-1 plan+1,800$2.710$5 K1,800Form 4
filed James G. McArthurPresident and CEO, DirectorSell10b5-1 plan-1,800$16.04$29 K0Form 4
filed Jaya GoyalEVP, Res. & Preclin. Dev.Option exercise10b5-1 plan+392$10.88$4 K392Form 4
filed Jaya GoyalEVP, Res. & Preclin. Dev.Sell10b5-1 plan-392$20.00$8 K0Form 4
filed Jaya GoyalEVP, Res. & Preclin. Dev.Option exercise10b5-1 plan+644$10.88$7 K644Form 4
filed Jaya GoyalEVP, Res. & Preclin. Dev.Sell10b5-1 plan-644$17.00$11 K0Form 4
filed Jaya GoyalEVP, Res. & Preclin. Dev.Option exercise10b5-1 plan+3,679$10.88$40 K3,679Form 4
filed Jaya GoyalEVP, Res. & Preclin. Dev.Sell10b5-1 plan-3,679$17.18$63 K0Form 4
filed Jaya GoyalEVP, Res. & Preclin. Dev.Option exercise10b5-1 plan+1,677$10.88$18 K1,677Form 4
filed Jaya GoyalEVP, Res. & Preclin. Dev.Sell10b5-1 plan-1,677$17.04$29 K0Form 4
filed Niels SvenstrupSVP, Chem. Mfg & ControlsOption exercise+10,000$2.710$27 K10,000Form 4
filed Oxford Science Enterprises plc10% ownerBuyamended+879,970$12.00$10.6 M4.76 MForm 4/A
filed Peter KolchinskyDirector, 10% ownerConversionindirect+3.64 M——3.64 MForm 4
filed Peter KolchinskyDirector, 10% ownerBuyindirect+2.98 M$12.00$35.8 M6.62 MForm 4
filed Peter KolchinskyDirector, 10% ownerConversionindirect+1.05 M——1.05 MForm 4
filed Peter KolchinskyDirector, 10% ownerBuyindirect+249,749$12.00$3.0 M1.30 MForm 4
filed Peter KolchinskyDirector, 10% ownerConversionindirect+207,672——207,672Form 4
filed Deerfield Private Design Fund V, L.P.10% ownerConversionindirect+268,480——268,480Form 4
filed Oxford Science Enterprises plc10% ownerConversion+1.26 M——1.38 MForm 4
filed Deerfield Private Design Fund V, L.P.10% ownerConversionindirect+268,480——268,480Form 4
filed Oxford Science Enterprises plc10% ownerConversion+945,859——2.33 MForm 4
filed Deerfield Private Design Fund V, L.P.10% ownerBuyindirect+208,333$12.00$2.5 M476,813Form 4
filed Oxford Science Enterprises plc10% ownerConversion+1.55 M——3.88 MForm 4
filed Deerfield Private Design Fund V, L.P.10% ownerBuyindirect+208,333$12.00$2.5 M476,813Form 4
filed Laurie KeatingDirectorBuy+4,166$12.00$50 K4,166Form 4

Source: SEC Forms 4 and 5. A trade under a 10b5-1 plan was scheduled in advance. For information only; not investment advice